James Brophy, MD, PhD
Cardiovascular epidemiology • medical decision making.
My research focuses on cardiovascular epidemiology and includes pharmacoepidemiology, systematic reviews, cost-effectiveness analyses and health technology assessments.
Bogaty P, Dagenais G, Joseph L, Boyer L, Leblanc A, Belisle P, Brophy JM. Time Variability of C-Reactive Protein: Implications for Clinical Risk Stratification. PLoS One 2013 Apr 8 8(4).
Etminan M, Bird ST, Delaney JA, Bressler B, Brophy JM. Isotretinoin and the risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data. JAMA Dermatol. 2013 Feb 1;149(2):216-20
Mayo NE, Mackay-Lyons MJ, Scott SC, Moriello C, Brophy JM. A randomized trial of two home-based exercise programmes to improve functional walking post-stroke. Clin Rehabil. 2013 Mar 15. [Epub ahead of print]
Almadi MA, Barkun A, Brophy JM. Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding. JAMA. 2011 Dec 7;306(21):2367-74. Epub 2011 Nov 1.
Bogaty P, Filion K, Brophy JM. Routine Invasive Management After Fibrinolysis in Patients With ST-Elevation Myocardial Infarction: A Systematic Review of Randomized Clinical Trials. BMC Cardiovasc Disord. 2011 Jun 20;11(1):34. [Epub ahead of print]